Ausgewählte Publikationen

 

2018

Seoane M, Buhs S, Iglesias P, Strauss J, Puller AC, Müller J, Gerull H, Feldhaus S, Alawi M, Brandner JM, Eggert D, Du J, Thomale J, Wild PJ, Zimmermann M, Sternsdorf T, Schumacher U, Nollau P, Fisher DE, Horstmann MA (2018) Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene.

IF 6.854

 

Keller EX, Bachofner J, Britschgi AJ, Saba K, Mortezavi A, Kaufmann B, Fankhauser CD, Wild P, Sulser T, Hermanns T, Eberli D, Poyet C (2018) Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer. World J. Urol.

IF 2.981

 

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U (2018) DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J. Clin. Invest. 129:223-229.

IF 13.250

 

Leão R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, Zhang C, Lipman T, Poyet C, Valtcheva N, Oehl K, Coelho H, Sayyid R, Gomes AM, Prado E Castro L, Sweet J, Vinagre J, Apolónio J, Stephens D, Faleiro I, Fadaak K, Richard PO, Kulkarni G, Zlotta AR, Hamilton RJ, Castelo-Branco P, Tabori U (2018) Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int. J. Cancer. 144:1676-1684.

IF 5.444

 

Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A (2018) Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort. J. Thorac. Oncol. 13:1851-1863.

IF 10.336

 

Arvaniti E, Fricker K S, Moret M, Rupp N, Hermanns T, Fankhauser C, Wey N, Wild P J, Rüschoff J H, Claassen M (2018) Automated Gleason grading of prostate cancer tissue microarrays via deep learning. Sci Rep. 8:12054.

IF 4.259

 

Guo T, Li L, Zhong Q, Rupp N J, Charmpi K, Wong C E, Wagner U, Rueschoff J H, Jochum W, Fankhauser C D, Saba K, Poyet C, Wild P J, Aebersold R, Beyer A (2018) Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers. Life Sci Alliance 1: e201800042.

 

Zhong Q, Wagner U, Kurt H, Molinari F, Cathomas G, Komminoth P, Barman-Aksözen J, Schneider-Yin X, Rey JP, Vassella E, Rogel U, Diebold J, McKee T, Jochum W, Kashofer K, Hofman P, Zischka M, Moch H, Rechsteiner M, Wild P J (2018) Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathol. Res. Pract. 214:957-963.

IF 2.994

 

Brandt L P, Albers J, Hejhal T, Pfundstein S, Gonçalves A F, Catalano A, Wild P J, Frew I J (2018) Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma. Oncotarget. 9:19753-19766.

IF 5.168